AFP is the widely used tumor biomarker for hepatocellular carcinoma (HCC) and germ cell tumors.[50] Serum AFP concentrations exhibit dynamic pathological characteristics from below 20 ng mL−1 in healthy and chronic liver disease patients to over 10,000 ng mL−1 in advanced HCC. This evidence concerns the gene AFP and hepatocellular carcinoma.